1-204113018-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_005686.3(SOX13):c.103G>A(p.Glu35Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000291 in 1,612,930 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000018 ( 0 hom. )
Consequence
SOX13
NM_005686.3 missense
NM_005686.3 missense
Scores
2
9
8
Clinical Significance
Conservation
PhyloP100: 4.50
Genes affected
SOX13 (HGNC:11192): (SRY-box transcription factor 13) This gene encodes a member of the SOX (SRY-related HMG-box) family of transcription factors involved in the regulation of embryonic development and in the determination of cell fate. The encoded protein may act as a transcriptional regulator after forming a protein complex with other proteins. It has also been determined to be a type-1 diabetes autoantigen, also known as islet cell antibody 12. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.14508012).
BS2
High AC in GnomAd4 at 20 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SOX13 | NM_005686.3 | c.103G>A | p.Glu35Lys | missense_variant | 2/14 | ENST00000367204.6 | NP_005677.2 | |
SOX13 | XM_047435006.1 | c.103G>A | p.Glu35Lys | missense_variant | 2/14 | XP_047290962.1 | ||
SOX13 | XM_005245623.4 | c.103G>A | p.Glu35Lys | missense_variant | 2/14 | XP_005245680.1 | ||
SOX13 | XM_047435007.1 | c.103G>A | p.Glu35Lys | missense_variant | 2/14 | XP_047290963.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SOX13 | ENST00000367204.6 | c.103G>A | p.Glu35Lys | missense_variant | 2/14 | 1 | NM_005686.3 | ENSP00000356172 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152216Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
20
AN:
152216
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000203 AC: 5AN: 246584Hom.: 0 AF XY: 0.00000745 AC XY: 1AN XY: 134268
GnomAD3 exomes
AF:
AC:
5
AN:
246584
Hom.:
AF XY:
AC XY:
1
AN XY:
134268
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1460596Hom.: 0 Cov.: 32 AF XY: 0.0000193 AC XY: 14AN XY: 726558
GnomAD4 exome
AF:
AC:
27
AN:
1460596
Hom.:
Cov.:
32
AF XY:
AC XY:
14
AN XY:
726558
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000131 AC: 20AN: 152334Hom.: 0 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74496
GnomAD4 genome
AF:
AC:
20
AN:
152334
Hom.:
Cov.:
33
AF XY:
AC XY:
8
AN XY:
74496
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 06, 2023 | The c.103G>A (p.E35K) alteration is located in exon 2 (coding exon 1) of the SOX13 gene. This alteration results from a G to A substitution at nucleotide position 103, causing the glutamic acid (E) at amino acid position 35 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Pathogenic
DEOGEN2
Benign
T;T;T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Pathogenic
D
MutationAssessor
Benign
L;.;.;L
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;D;N;.
REVEL
Uncertain
Sift
Uncertain
D;D;D;.
Sift4G
Benign
T;D;T;T
Polyphen
P;.;.;P
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at